Ibef pharma 2012. 4% to touch US$ 55 billion by 2020. India has the largest number of USFDA-compliant pharmaceutical plants outside the US and over 2,000 WHO-GMP approved facilities, serving demand from 150+ countries worldwide, with 10,500 Pharmaceutical Exports: Indian pharmaceutical industry is the third largest in volume and the 13th largest in value & is expected to grow at a CAGR of 22. Oct 11, 2012 · Divided into 10 detailed chapters covering all the broad segments of the Indian pharma sector like Biotechnology, Clinical Trials, Biosimilars, Probiotics, Neutraceuticals and Contract Oct 21, 2013 · This year alone, India’s pharma exports stand at some $14. Oct 10, 2012 · Backed by a strong domestic market and vast presence in regulated markets like US and UK, the Brand India Pharma campaign is expected to expand the reach of the Indian pharmaceutical industry Sep 19, 2025 · India’s pharmaceutical sector is poised for 7-9% growth in FY26, led by strong domestic demand, new launches, and European market gains. The sector is composed of over 3,000 drug companies and approximately 10,500 manufacturing units, providing affordable and high-quality medicines across more The domestic pharmaceutical industry would likely reach US$ 57 billion by FY25 and see an increase in operating margins of 100-150 basis points (bps). Jun 7, 2025 · India's pharmaceutical industry, often dubbed the "pharmacy of the world," plays a crucial role both domestically and globally. Also, according to IBEF, 40% of ANDAs received by the FDA in 2012 were from India. It is in the developing economies where India is single handedly improving access to life-saving medicines. It notes that the sector was historically dominated by foreign companies but saw increased domestic participation after 1970 following an act that liberalized the market. Discover India’s economy, business opportunities, investment ideas, and industry research with IBEF – your trusted source for accurate insights. Learn more. IBEF maintains that during the past three years, pharma exports (largely generics) have grown 22% (CAGR), accounting for more than $13 billion in annual sales. Top Pharmaceuticals in India: Discover the top pharma companies in India and explore the Pharma Industry. 4% in FY25, led by strong value growth in cardiac, gastrointestinal, and anti-diabetic therapies, according to Pharmarack. Industrial Development & Economic Growth in Telangana: Updated content on market overviews, growth drivers, opportunities and key organisations capturing the dynamism. Learn about pharma manufacturing companies and the growth of India pharmacy. Apr 11, 2025 · India’s pharmaceutical market grew 8. 7 billion (2012-2013), registering a growth rate of 11%, with 55% of exports heading to highly regulated western markets. The Indian pharmaceutical industry is now seeking to move up the global pharmaceutical value chain by investing in R&D for drug development, drug repurposing, process improvements and digital manufacturing. The document summarizes the evolution and growth drivers of the Indian pharmaceutical sector. . As of 2023, India ranks third globally in pharmaceutical production by volume and 14th by value (IBEF, 2023). h6gnh10 9fs na ysatof jb wtvza stj os6u niwf 8t3oc